Regeneron Pharmaceuticals, Inc.

The 2025 Nobel Prize in Physiology or Medicine <a href="https://www.nobelprize.org/prizes/medicine/2025/press-release/">was awarded to</a> Mary E. Bruncoe, Fred Ramsdell and Shimon Sakaguchi for discoveries in the workings of the immune system that pave the way for treatments for autoimmune diseases and cancer, as well as easier organ transplantation. The mechanism they discovered is called peripheral immune tolerance - sounds confusing, let's figure it out.

Rabbits vs. scientific dogma: what you need to know about the Nobel Prize in Medicine

The fact that artificial intelligence is used in almost all spheres of human life is no surprise to anyone. But the case of Albania, where the first virtual minister appeared in September this year and was allowed to distribute public finances, raises many important questions. Among them is how actively AI should be involved in government management and how it should be controlled. Vadim Novikov, Advisor to the President of Almaty Management University (AlmaU), discusses this.

The Altar of Power and the Machine: Will Artificial Intelligence Replace the State?

Cronos Group Inc.

Canopy Growth Corporation

Tilray Brands, Inc.

An exchange-traded fund tracking the industry has fallen 90% in price since the peak of investment in marijuana growers

Trump released a video about marijuana products. Producers' stocks went up

Ionis Pharmaceuticals, Inc.

Quotes of biotech Ionis Pharmaceuticals jumped 35% in a single day after it announced a successful trial of a drug that reduces triglyceride levels in the blood and prevents cases of acute pancreatitis. Analysts were positive about the results. The company, which is known for its Spinraza drug for spinal muscular atrophy, could see its shares rise another 40%, according to some analysts' models.&nbsp;

Biotech Ionis Pharmaceuticals surges 35% after upbeat trial of triglyceride drug

Shoulder Innovations, Inc.

Shares of Shoulder Innovations, a small-cap maker of shoulder implants, <a href="https://finance.yahoo.com/quote/SI/">surged</a>&nbsp;more than 18% yesterday, August 25, after at least four Wall Street analysts <a href="https://www.cnbc.com/2025/08/25/goldman-says-this-specialized-medical-implant-stock-has-more-than-50percent-upside.html">initiated </a>coverage with bullish calls. Goldman Sachs, for example, set a target price that implies upside of more than a third.

Four banks initiate coverage with 'buy' call on Shoulder Innovations; shares soar

Tesla, Inc.

Meta Platforms, Inc.

In mid-August, it became known that OpenAI CEO Sam Altman intends to <a href="https://www.ft.com/content/04484164-724e-4fc2-92a2-e2c13ea639bd">back</a> Merge Labs, a company that is developing a brain-computer interface - a class of technology that allows people to control computers using neural signals from the brain, i.e., actually by the power of thought. This further intensifies competition with his former partner and now rival Elon Musk, who launched a similar startup, Neuralink, in 2016. So far, the technology is being used with the noble goal of helping completely paralyzed people to communicate with the world around them again by controlling computer interfaces. However, both billionaires believe that in the long run, this technology will literally save humanity from extinction.

The great merger: why billionaires are getting in our heads

Heartflow, Inc.

The company raised $316.7 million, more than it had expected

Medtech Heartflow IPOs, shares now available for Freedom clients

Shares of Shoulder Innovations, a medical company that develops implants for shoulder surgeries, became available July 31 on the Freedom client trading system. The securities are listed under the ticker <a href="https://tap.freedom24.com/to/quote/SI.US?utm_source=stocks&amp;utm_medium=SI.US&amp;utm_campaign=pfu8656964">SI</a>. They will appear on the New York Stock Exchange in a few hours.&nbsp;

Shoulder Innovations IPO: shares of medtech with AI solutions for surgery become available


Pheton Holdings Ltd

Chinese micro-cap company Pheton Holdings, whose shares trade on the Nasdaq, <a href="https://finance.yahoo.com/quote/PTHL/">crashed</a> and lost nearly 95% of its value yesterday, July 29. Investors were reacting to a <a href="https://thebearcave.substack.com/p/problems-at-pheton-holdings-pthl">report</a> by the Bear Cave, a newsletter that "exposes corporate misconduct," which alleged that Pheton is "being manipulated by overseas stock manipulation groups and is at risk of a near-term, severe stock collapse" and called on regulators to halt trading in the stock before U.S. investors lost millions.

Chinese micro-cap company Pheton loses 95% in a day on allegations of pump-and-dump

Eli Lilly and Company

Novo Nordisk A/S

China has entered the race in the market of weight loss drugs: several companies from China have presented their products that may become competitors to Ozempic, Mounjaro and other hits from Novo Nordisk and Eli Lilly. The first of these received regulatory approval in June. In general, Chinese biotech has survived the prolonged "nuclear winter" and is now actively developing. What should an investor know about it?

The end of nuclear winter and tens of percent growth: how China is growing its pharma giants


Auna SA

Latin America is seeing growing demand for private healthcare services amid chronic undercapacity in the public system. While in OECD countries (comprising over 35 developed economies, like the U.S., Canada and Germany) public and mandatory insurance schemes <a href="https://privatebank.jpmorgan.com/latam/en/insights/markets-and-investing/ideas-and-insights/healthy-growth-for-latin-america-tapping-the-regions-healthcare-sector-for-economic-gains#:~:text=pandemic%252C%2520compared%2520with%2520just%252019,tiered%2520system">cover</a>&nbsp;74% of total health expenditure, in Latin America the figure stands at just 57%. The remaining burden falls on private insurance and out-of-pocket payments, supporting the expansion of private medical providers and insurers. At the same time, several countries in the region <a href="https://privatebank.jpmorgan.com/latam/en/insights/markets-and-investing/ideas-and-insights/healthy-growth-for-latin-america-tapping-the-regions-healthcare-sector-for-economic-gains#:~:text=bottom%2520of%2520the%2520chart%252C%2520Argentina,281">face shortages</a> of physicians and medical services, a further driver of growth for private clinics.

Auna: The Peruvian small cap developing private health care in Latin America



SS Innovations International, Inc.

SS Innovations, a developer of surgical robotic technologies, soared 42% yesterday, June 18. That is how investors reacted to the news of the successful completion of its first robotic cardiac surgery in the Western Hemisphere. The stock has been trading on the Nasdaq for only about two months.

#Medicine: 14